RadNet, Inc.
- RDNT
- NASDAQ
- Medical - Diagnostics & Research
- Diagnostic Imaging (MRI/CT)
$69.43
Today +0.92%Quote Oct 19, 2026, 02:05 PM UTC
−11.55%over the last month
Max drawdown −13.0%From 1-month high −11.5%3 months +13.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$5.46B
Quote Oct 19
Next earnings
Nov 9
Expected, not confirmed
Analyst target
$65.00
−6.4% from here
Floor
$68.73
1.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RDNTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $622.7M
- Commercial Insurance1$339.4M54.5%
- Medicare1$150.8M24.2%
- Capitation Arrangements$30.1M4.8%
- Health Care, Other$29.7M4.8%
- Medicaid1$14.5M2.3%
- Workers' Compensation/Personal Injury1$13.5M2.2%
- Health Care, Management Service$7.9M1.3%
- Other / not reported$36.8M5.9%
Industry
Medical - Diagnostics & Research
Employees
9,060